Three-way sensitivity analysis of the cost per TB case detected. by Patricia Turimumahoro (4574023)

Subjects:

Flow chart of stakeholder’s selection. by Folahanmi T. Akinsolu (16557914)

Subjects:

Summary of planned model input strategy. by Matt Kasman (5327240)

Subjects:

Outcome measures collected from trainees via tablet in pre- and post-training surveys. by Kathryn E. L. Grimes (9202013)

Subjects:

Conceptual framework: influences on children’s physical activity will initially be based on a review of extant literature. by Matt Kasman (5327240)

Subjects:

Socio-demographic characteristics of the study participants in the KIIs and FGDs. by Folahanmi T. Akinsolu (16557914)

Subjects:

EFA and CFA results for the final 6-item self-efficacy to resist unwanted advances scale. by Kathryn E. L. Grimes (9202013)

Subjects:

Bottom-up unit cost estimates for each activity and resource category per household TB contact investigated. by Patricia Turimumahoro (4574023)

Subjects:

EFA and CFA results for the final 8-item bystander intentions scale. by Kathryn E. L. Grimes (9202013)

Subjects:

Stacked bar showing distribution of total estimated vertical transmission in 2021 by timing of infections and ART status. by Pradeep Kumar (310858)

Subjects:

EFA and CFA results for the final 8-item date rape attitudes scale. by Kathryn E. L. Grimes (9202013)

Subjects:

MTCT rate in 2021, India and select states. by Pradeep Kumar (310858)

Subjects:

Socio-economic status of the participants. by Sohini Paul (17965575)

Subjects:

A detailed description of program activities in the different phases of implementation. by Patricia Turimumahoro (4574023)

Subjects:

Clinic characteristics. by Patricia Turimumahoro (4574023)

Subjects:

Key epidemiological characteristics of the states selected. by Pradeep Kumar (310858)

Subjects:

Key elements of the interview guide. by Folahanmi T. Akinsolu (16557914)

Subjects:

Summary of codes. by Kaitlyn Atkins (8293719)

Subjects:

Peripartum and postpartum probability of HIV transmission by prophylaxis/treatment regimen (%). by Pradeep Kumar (310858)

Subjects:

Composition of key informant interview and focused group discussion. by Folahanmi T. Akinsolu (16557914)

Subjects: